Profile
Jennifer Maggio worked as Director-Finance & Accounting at Accuray, Inc. from 2006 to 2011.
She then worked as Vice President & Controller at SI-BONE, Inc. She also worked as Controller at Ventus Medical, Inc. in 2012.
Recently, she worked as Vice President & Controller at Seer, Inc. (California) from 2020 to 2022.
Ms. Maggio completed her undergraduate degree from The California State University in 2000.
Former positions of Jennifer Maggio
| Companies | Position | End |
|---|---|---|
| SEER, INC. | Comptroller/Controller/Auditor | 30/06/2022 |
Ventus Medical, Inc.
 Ventus Medical, Inc. Medical SpecialtiesHealth Technology Ventus Medical manufactured and distributed medical devices Located in Belmont, California, Ventus Medical has developed a new breakthrough therapy for obstructive sleep apnea (OSA). OSA afflicts roughly 50 million people in the United States alone, and existing solutions do not always meet patient's needs. Through truly innovative technology, solid clinical evidence, and a focus on the patient, Ventus Medical seeks to deliver consumer-preferred, physician-recommended solutions. Ventus Medical has conducted several randomized clinical studies across the United States and has received FDA clearance for PROVENT Sleep Apnea Therapy. | Comptroller/Controller/Auditor | 30/09/2012 |
| ACCURAY INCORPORATED | Director of Finance/CFO | 30/11/2011 |
| SI-BONE, INC. | Comptroller/Controller/Auditor | - |
Training of Jennifer Maggio
| The California State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SI-BONE, INC. | Health Technology |
| ACCURAY INCORPORATED | Health Technology |
| SEER, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ventus Medical, Inc.
Ventus Medical, Inc. Medical SpecialtiesHealth Technology Ventus Medical manufactured and distributed medical devices Located in Belmont, California, Ventus Medical has developed a new breakthrough therapy for obstructive sleep apnea (OSA). OSA afflicts roughly 50 million people in the United States alone, and existing solutions do not always meet patient's needs. Through truly innovative technology, solid clinical evidence, and a focus on the patient, Ventus Medical seeks to deliver consumer-preferred, physician-recommended solutions. Ventus Medical has conducted several randomized clinical studies across the United States and has received FDA clearance for PROVENT Sleep Apnea Therapy. | Health Technology |
- Stock Market
- Insiders
- Jennifer Maggio
